Direkt zum Inhalt
Merck
Alle Fotos(2)

Key Documents

View All Documentation

481181

Sigma-Aldrich

Silber(I)-sulfadiazin

98%

Synonym(e):

Sulfadiazin-Silber

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(2)

About This Item

Empirische Formel (Hill-System):
C10H9AgN4O2S
CAS-Nummer:
22199-08-2
Molekulargewicht:
357.14
EG-Nummer:
244-834-5
MDL-Nummer:
MFCD00072101
UNSPSC-Code:
12352302
PubChem Substanz-ID:
24871745
NACRES:
NA.23

Qualitätsniveau

100

Assay

98%

Form

powder

mp (Schmelzpunkt)

285 °C (dec.) (lit.)

SMILES String

Nc1ccc(cc1)S(=O)(=O)N([Ag])c2ncccn2

InChI

1S/C10H9N4O2S.Ag/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10;/h1-7H,11H2;/q-1;+1

InChIKey

UEJSSZHHYBHCEL-UHFFFAOYSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Anwendung

Silver(I) sulfadiazine (AgSD) is popularly used for treating second-degree burn wounds as it acts as an antimicrobial agent and prevents infections. Silver sulfadiazine-impregnated polyurethane (PU) foam, chitosan/chondroitin sulfate films may be used for wound dressing.

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 2

Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number
MKCN0160
MKCJ6788
MKCF4686
MKBW7390V
MKBT4309V

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Suche nach COA

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Jason Wasiak et al.
The Cochrane database of systematic reviews, 3(3), CD002106-CD002106 (2013-04-02)
An acute burn wound is a complex and evolving injury. Extensive burns produce systemic consequences, in addition to local tissue damage. Treatment of partial thickness burn wounds is directed towards promoting healing and a wide variety of dressings are currently
Ayse Ebru Sakallioglu Abali et al.
Journal of burn care & research : official publication of the American Burn Association, 33(6), e309-e312 (2012-11-13)
As a superstition, homemade decoctions are believed to be beneficial for several diseases. This kind of medical therapy, however, can lead to serious adverse effects. In this report, we present three cases from a single family. Each of the family
Silver sulfadiazine-a new topical therapy for pseudomonas in burns: therapy of pseudomonas infection in burns
Fox CL
Archives of Surgery (Chicago, Ill. : 1960), 96(2), 184-188 (1968)
David J Leaper et al.
International wound journal, 9 Suppl 2, 1-19 (2013-01-05)
The TIME acronym (tissue, infection/inflammation, moisture balance and edge of wound) was first developed more than 10 years ago, by an international group of wound healing experts, to provide a framework for a structured approach to wound bed preparation; a
Meenakshi Venkataraman et al.
AAPS PharmSciTech, 14(1), 254-264 (2013-01-01)
The objective of the present study was to formulate stable silver sulfadiazine (SSD) nanosuspensions and nanogels suitable for topical delivery with a view to increase bactericidal activity in burn therapy. SSD nanosuspensions were formulated using the microprecipitation-high-pressure homogenization technique. An
Alle zugehörigen Dokumente anzeigen

Artikel

Gold Nanorod Synthesis

Plasmonic nanoparticles have unique optical properties that can be tailored to suit a variety of applications in the biotechnology1–8 and electronics9–16 industries.

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.